Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma

DSpace Repository

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma

Author: Leypoldt, Lisa B.; Tichy, Diana; Besemer, Britta; Haenel, Mathias; Raab, Marc S.; Mann, Christoph; Munder, Markus; Reinhardt, Hans Christian; Nogai, Axel; Goerner, Martin; Ko, Yon-Dschun; de Wit, Maike; Salwender, Hans; Scheid, Christof; Graeven, Ullrich; Peceny, Rudolf; Staib, Peter; Dieing, Annette; Einsele, Hermann; Jauch, Anna; Hundemer, Michael; Zago, Manola; Pozek, Ema; Benner, Axel; Bokemeyer, Carsten; Goldschmidt, Hartmut; Weisel, Katja C.
Tübinger Autor(en):
Besemer, Britta
Zago, Manola
Published in: Journal of Clinical Oncology (2024), Bd. 42, H. 1, S. 26-37
Verlagsangabe: Philadelphia : Lippincott Williams & Wilkins
Language: English
Full text: http://dx.doi.org/10.1200/JCO.23.01696
ISSN: 0732-183X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)